These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 28353116)

  • 1. Repository corticotropin for Chronic Pulmonary Sarcoidosis.
    Baughman RP; Sweiss N; Keijsers R; Birring SS; Shipley R; Saketkoo LA; Lower EE
    Lung; 2017 Jun; 195(3):313-322. PubMed ID: 28353116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repository corticotropin injection in patients with advanced symptomatic sarcoidosis: retrospective analysis of medical records.
    Chopra I; Qin Y; Kranyak J; Gallagher JR; Heap K; Carroll S; Wan GJ
    Ther Adv Respir Dis; 2019; 13():1753466619888127. PubMed ID: 31722624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results From a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Repository Corticotropin Injection for the Treatment of Pulmonary Sarcoidosis.
    Mirsaeidi M; Baughman RP; Sahoo D; Tarau E
    Pulm Ther; 2023 Jun; 9(2):237-253. PubMed ID: 37072607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A composite score to assess treatment response in pulmonary sarcoidosis: the Sarcoidosis Treatment Score (STS).
    Baughman RP; Tillinger M; Qin Y; Sweiss N; Lower EE
    Sarcoidosis Vasc Diffuse Lung Dis; 2019; 36(1):86-88. PubMed ID: 32476940
    [No Abstract]   [Full Text] [Related]  

  • 5. Management of repository corticotrophin injection therapy for pulmonary sarcoidosis: a Delphi study.
    Rahaghi FF; Sweiss NJ; Saketkoo LA; Scholand MB; Barney JB; Gerke AK; Lower EE; Mirsaeidi M; O'Hare L; Rumbak MJ; Samavati L; Baughman RP
    Eur Respir Rev; 2020 Mar; 29(155):. PubMed ID: 32198219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No evidence found for an association between prednisone dose and FVC change in newly-treated pulmonary sarcoidosis.
    Broos CE; Poell LHC; Looman CWN; In 't Veen JCCM; Grootenboers MJJH; Heller R; van den Toorn LM; Wapenaar M; Hoogsteden HC; Kool M; Wijsenbeek MS; van den Blink B
    Respir Med; 2018 May; 138S():S31-S37. PubMed ID: 29137908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective pilot study examining the use of Acthar gel in sarcoidosis patients.
    Baughman RP; Barney JB; O'Hare L; Lower EE
    Respir Med; 2016 Jan; 110():66-72. PubMed ID: 26626451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential additional benefit of infliximab in patients with chronic pulmonary sarcoidosis already receiving corticosteroids: a retrospective analysis from a randomized clinical trial.
    Judson MA; Baughman RP; Costabel U; Mack M; Barnathan ES
    Respir Med; 2014 Jan; 108(1):189-94. PubMed ID: 24361164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pain and Fatigue Improvements in Patients Treated with Repository Corticotropin Injection Across Five Indications: A Narrative Review.
    Girman C; Panaccio MP; Hayes K; Niewoehner J; Wan GJ
    Adv Ther; 2022 Jul; 39(7):3072-3087. PubMed ID: 35635646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of a randomized controlled trial to evaluate effectiveness of methotrexate versus prednisone as first-line treatment for pulmonary sarcoidosis: the PREDMETH study.
    Kahlmann V; Janssen Bonás M; Moor CC; van Moorsel CHM; Kool M; Kraaijvanger R; Grutters JC; Overgaauw M; Veltkamp M; Wijsenbeek MS;
    BMC Pulm Med; 2020 Oct; 20(1):271. PubMed ID: 33076885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-FDG PET as a predictor of pulmonary function in sarcoidosis.
    Keijsers RG; Verzijlbergen EJ; van den Bosch JM; Zanen P; van de Garde EM; Oyen WJ; Grutters JC
    Sarcoidosis Vasc Diffuse Lung Dis; 2011 Oct; 28(2):123-9. PubMed ID: 22117503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follow-up results of myositis patients treated with H. P. Acthar gel.
    Saygin D; Oddis CV; Marder G; Moghadam-Kia S; Nandkumar P; Neiman N; Dzanko S; Koontz D; Aggarwal R
    Rheumatology (Oxford); 2020 Oct; 59(10):2976-2981. PubMed ID: 32160301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repository Corticotropin Injection for the Treatment of Pulmonary Sarcoidosis: A Narrative Review.
    Mirsaeidi M; Baughman RP
    Pulm Ther; 2022 Mar; 8(1):43-55. PubMed ID: 35113366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of mycophenolate mofetil in sarcoidosis.
    Hamzeh N; Voelker A; Forssén A; Gottschall EB; Rose C; Mroz P; Maier LA
    Respir Med; 2014 Nov; 108(11):1663-9. PubMed ID: 25301291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acthar Gel (repository corticotropin injection) for persistently active SLE: study design and baseline characteristics from a multicentre, randomised, double-blind, placebo-controlled trial.
    Askanase AD; Zhao E; Zhu J; Connolly-Strong E; Furie RA
    Lupus Sci Med; 2020; 7(1):e000383. PubMed ID: 32399253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding Predictors of Response to Repository Corticotropin Injection Treatment Among Patients With Advanced Symptomatic Sarcoidosis.
    Bindra J; Chopra I; Hayes K; Niewoehner J; Panaccio MP; Wan GJ
    J Health Econ Outcomes Res; 2022; 9(1):90-100. PubMed ID: 35529249
    [No Abstract]   [Full Text] [Related]  

  • 17. Patient-Reported Outcomes from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar
    Askanase AD; Wan GJ; Panaccio MP; Zhao E; Zhu J; Bilyk R; Furie RA
    Rheumatol Ther; 2021 Mar; 8(1):573-584. PubMed ID: 33687687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repository corticotropin injection (H.P. Acthar gel) for the treatment of sarcoidosis-induced hypercalciuria and vitamin D dysregulation: a pilot, open label study.
    Judson MA; Modi A; Ilyas F; Yucel R
    Sarcoidosis Vasc Diffuse Lung Dis; 2018; 35(3):192-197. PubMed ID: 32476902
    [No Abstract]   [Full Text] [Related]  

  • 19. Double-blind, randomized trial of dexmethylphenidate hydrochloride for the treatment of sarcoidosis-associated fatigue.
    Lower EE; Harman S; Baughman RP
    Chest; 2008 May; 133(5):1189-95. PubMed ID: 18263672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate as a single agent for treating pulmonary sarcoidosis: a single centre real-life prospective study.
    Goljan-Geremek A; Bednarek M; Franczuk M; Puścińska E; Nowiński A; Czystowska M; Kamiński D; Korzybski D; Stokłosa A; Kowalska A; Wojda E; Sliwiński P; Burakowska B; Ptak J; Barańska I; Drygalska A; Małek G; Bestry I; Wesołowski S; Kram M; Górecka D
    Pneumonol Alergol Pol; 2014; 82(6):518-33. PubMed ID: 25339562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.